• American Regent Announces CEO Transition for 2021 americanpharmaceuticalreview
    November 25, 2020
    American Regent, a Daiichi Sankyo Group company, announced Ken Keller, currently serving as the company's President and CEO, is transitioning to a new role as the Global Head of Oncology Business at Daiichi Sankyo, effective April 1, 2021.
PharmaSources Customer Service